Evidence Synthesis
Here is the standard_shift narrative based on the provided payload: Artemis Med's quarterly gross margin accelerated to 22.91%, up from 15.22%.
The company's marginal operating leverage also accelerated to , from 10.21%. Revenue growth year-over-year decelerated to , down from 46.7%. Daily volume surged to 973,919 shares, up 2.5 times from the previous quarter. The stock price closed at 326.1 INR, up 1.48% from the previous close of 321.3 INR. Analyst sentiment weakened, with no strong buys and a score of 1.